Iridex Eyes BRICs To Laser Ahead

The growth of laser eye surgery in emerging markets offers huge opportunities for Iridex, says the company's CFO James Mackaness.
Author:
Publish date:

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.